ARID2 and cutaneous melanoma: We also analyzed the prevalence of loss of heterozygosity in cutaneous melanoma and observed that patients with ARID1A mutation had higher prevalence compared to those with ARID2 mutation (15.38% vs 4.46%, q = 0.044)—Fig. 2b.